Mimic ligand-binding sites of the nicotinic acetylcholine receptor bind d-tubocurarine and a-bungarotoxin in vitro. Injection of such binding sites into mice could act as molecular decoys in vivo, providing protection against toxic ligands. This hypothesis of molecular "decoyance" has been tested in >250 mice. Bacterially produced cholinergic binding sites provided a 2-fold increase in the survival rate of animals challenged with curarimimetic neurotoxins. Possible considerations for decoy designs and their applications are discussed.
MATERIALS AND METHODS Production of R4137. Oligonucleotides corresponding to the a-amino acid sequence 184-200 were synthesized on an Applied Biosystems 380B DNA automated synthesizer by Ora Goldberg (Weizmann Institute of Science). The synthetic double-stranded DNA was then cloned into the Sma I site of the bacterial expression vector pATH2 (10, 12, 13) . Escherichia coli HB101 competent cells were then transformed with these plasmids and a-BTX-binding transformants were selected by toxin overlay of colony blots as described (10) . A preparation enriched for the fusion protein (designated R4137) was prepared as follows. Starter cultures of R4137 clones were grown overnight on Luria broth medium containing ampicillin (30 ,ug/ml) and then used to inoculate (1:100) M9 medium (50-500 ml) supplemented with 0.5% (wt/vol) Casamino acids, thiamine (5 ,ug/ml), and 3-,findoleacrylic acid (5 ,ug/ml) as described (10) . The cultures were grown at 330C for 12 hr and reached a density of [1] [2] OD60. The cells were then pelleted by centrifugation and washed in phosphate-buffered saline. They were finally resuspended to 1/10th their original volume in a high salt (500 mM NaCl) phosphate buffer (pH 7.4) containing 1 mM EDTA, 1 mM 1,4-dithiothreitol, 1 mM phenylmethylsulfonyl fluoride. The cells were disrupted by sonication in a Branson sonicator operated at 1/3rd its maximal output (0.5-1 min on ice). The pelletable material was separated from the soluble fraction by centrifugation (10 min at 3000 rpm in a Sorvall SS-34 rotor). The pellet was then resuspended by sonication in water. The suspension was centrifuged as described above and the supernatant was collected. This fraction was found to be highly enriched in R4137. It was either used directly or stored at 4TC until use.
Polyacrylamide Gel Electrophoresis and Protein Blotting. Toxin overlays of protein blots were done essentially as described (6, 10) . Total bacterial homogenates (equivalent to 0.5 OD6.) or the enriched preparation of R4137 were separated on 10% polyacrylamide slab gels as described (6, 14) . The gels were blotted to nitrocellulose membrane filters (Schleicher & Schuell; 0.45-,um BA85) with a blot apparatus equipped with an electrode array designed to produce a gradient electric field (50-8 V) (15) . The blots were quenched with 1% hemoglobin in phosphate-buffered saline and probed with 125I-labeled a-BTX (1-5 x 106 cpm; 1-5 x 10-9 M) overnight. The ... to cause 80%o death of untreated mice. The toxins were administered to the animals by subcutaneous injection at the nape ofthe neck. The animals were observed and the number of deaths during the course of 2 hr after the toxin injection was recorded. All the survivors were kept at least 24 hr and in some cases for as long as 1 week.
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RESULTS
The region of residues 180-200 of the a-subunit of the AcChoR derived from T. californica has been found to bind curarimimetic neurotoxins (9, 10, 17) . Table 1 .
As shown in Fig. 2 , a highly enriched fraction of R4137 can be prepared from E. coli transformants. Cells grown under inductive conditions produce a 36-kDa fusion protein as a major band. This polypeptide is unique for toxin binding. In high salt buffer (500 mM NaCl), this protein is less soluble than it is in low salt. This characteristic has been exploited and, by differential centrifugation and sonication, a soluble fraction containing predominantly R4137 is easily obtained (lanes A and C) .
In view of the fact that R4137 binds curarimimetic neurotoxins, it was conceivable that it may serve as a decoy, having a protecting effect in vivo, should it be injected into animals. Therefore, 5-wk-old BALB/c males were injected with R4137 or a similar fraction derived from pATH2-transformed bacteria. Five minutes after "priming" ofthe mice, they were challenged with d-tubocurarine and the rate of death was recorded for each group. As shown in Fig. 3 , R4137 had a profound effect (>3-fold increase) on the survival rate of the mice. To ascertain that this effect was not peculiar to males or unique to inbred mice, males and females of CD1 outbred mice were also tested. The results for >200 mice injected with d-tubocurarine are given in Table 2 ). Mice were injected with R4137 or pATH2 preparations as indicated and challenged 5 min later with d-tubocurarine (Tubo) or a-CTX. The number of survivors 2 hr after the toxin injection is given.
interest to test whether R4137 would have any protecting effect on mice injected with this toxin.
As shown in Table 2 , 61 CD1 male mice were tested. For the course of the experiment (2 hr after toxin injection), R4137 had a dramatic effect. However, by 24 hr after the toxin was injected, all 61 mice were found dead. This transient effect of R4137 most probably reflects dissociation of the toxin from the decoy and gradual lethal accumulation of the a-CTX at the neuromuscular junction. No such effect was found in the d-tubocurarine-tested mice, and survivors appeared to be healthy even 1 wk after the experiment. 
DISCUSSION
